EssilorLuxottica Valuation Contracts Sharply Amid Profitability Concerns

Shares of EssilorLuxottica (ESLX) have experienced a significant valuation reset following a sharp decline in 2026, but signs of weakening profitability are creating a complex picture for investors. The stock has fallen 46.33% year-to-date, bringing its market capitalization to €66.50 billion as of September 25.

A Tale of Two Metrics

The core of the current debate among investors centers on the divergence between the company's revenue growth and its profitability. While EssilorLuxottica's revenue grew at an annualized rate of roughly 9.5% from 2021 to 2025, its margins have come under pressure.

Key financial indicators highlight this challenge:

• Gross Margin: Fell to 59.7% in 2025 from 62.4% in 2024.
• Net Income: Declined to €2.31 billion in 2025 from €2.36 billion the prior year.
• Valuation: The stock now trades at a forward price-to-earnings (P/E) ratio of 20.4x, a significant derating from previous levels.

The Bull and Bear Cases

Ad

Optimistic investors, or bulls, point to the company's lower valuation as an opportunity. Analysts at Goldman Sachs, for example, argued in a June note that the stock's price had become disconnected from its growth outlook. Despite reducing their price target to €230, they maintained a Buy rating on the shares.

Conversely, bears focus on the tangible evidence of margin compression. Headwinds cited by analysts include tougher year-over-year comparisons, foreign-exchange pressure, and weaker consumer confidence. Furthermore, brand risk has emerged as a concern, stemming from controversy around the Ray-Ban Meta smart glasses and reports of governance tensions, which could threaten the premium multiple the company has historically commanded.

Outlook: A Contrarian Play Awaiting a Catalyst

At its current valuation, EssilorLuxottica is no longer priced for flawless execution. For the stock to rebound, investors will be watching for clear signals of operational improvement.

The market is looking for confirmation on several fronts: stabilization in profit margins, resilience in revenue estimates, and evidence that the core Ray-Ban brand remains strong. The performance of its wearables division and its ability to contribute to growth without further diluting group profitability will also be critical. Until these factors provide a clear catalyst, the stock remains a credible contrarian idea but not yet a low-risk value story.